Status:
RECRUITING
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Inflammatory Bowel Diseases
Crohn Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic biomarkers of natural histor...
Detailed Description
Percentage of primary responders who haven't lost response to biotherapies during follow-up (anti-TNF, ustekinumab, vedolizumab). Response to treatment will be evaluated using objective criteria for ...
Eligibility Criteria
Inclusion
- Age\>=18 years
- Patients with an established diagnosis of CD or UC (clinical, biological, radiological, endoscopic or histologic criteria)
- Patients \>=45 kg
- Affiliated member of the Social Security system
Exclusion
- Patients with an undetermined colitis
- Patients with a non established diagnosis of CD
- Women of childbearing age without a method of contraception
- Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code
- Pregnant women, breastfeeding women
- \-- Age \< 18 years
- Persons under legal protection
- Person who does not have the capacity to consent
- Persons under the age of 18 years who are deprived of their liberty by decision of a judicial or administrative authority (articles L. 3212-1 and L. 3213-1).
Key Trial Info
Start Date :
December 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2034
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03809728
Start Date
December 10 2019
End Date
December 10 2034
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Vandœuvre-lès-Nancy, France, 54510